The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

The survival of patients diagnosed with metastatic renal cell carcinoma (RCC) is still limited and the current targeted therapies are only partially effective. Herein, we investigated the clinical value and functions of adiponectin receptors (AdipoR1 and AdipoR2) in metastatic renal cell carcinoma (...

Full description

Bibliographic Details
Main Authors: Guangxi Sun, Xingming Zhang, Zhenhua Liu, Sha Zhu, Pengfei Shen, Haoran Zhang, Mengni Zhang, Ni Chen, Jinge Zhao, Junru Chen, Jiandong Liu, Jindong Dai, Zhipeng Wang, Xudong Zhu, Yufang Wang, Hao Zeng
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558619301654